Nécrolyse épidermique toxique due à l’ipilimumab et au nivolumab chez une patiente souffrant d’un mélanome métastatique

Authors

  • Marika Lepage-Légaré Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Estrie, CHU de Sherbrooke
  • Sandrine Léger Centre intégré de santé et de services sociaux (CISSS) de Laval, Hôpital de la Cité-de-la-Santé
  • Hugo Ricignuolo Centre intégré de santé et de services sociaux (CISSS) de Laval, Hôpital de la Cité-de-la-Santé
  • Gabrielle St-Louis Centre intégré de santé et de services sociaux (CISSS) de Laval, Hôpital de la Cité-de-la-Santé
  • Thomas Joly-Mischlich Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Estrie, CHU de Sherbrooke

DOI:

https://doi.org/10.4212/cjhp.v74i3.3158

Downloads

Download data is not yet available.

Downloads

Published

2021-07-05

Issue

Vol. 74 No. 3 (2021)

Section

Case Report(s) / Observation(s) clinique(s)

License

Copyright © Canadian Society of Healthcare-Systems Pharmacy.

After publication of a manuscript in the CJHP, the authors of the manuscript must obtain written permission from the CSHP (publications@cshp.ca) before reproducing any text, figures, tables, or illustrations from the work in future works of their own. If a submitted manuscript is declined for publication in the CJHP, all said rights shall revert to the authors. Please note that any forms (e.g., preprinted orders and patient intake forms) used by a specific hospital or other health care facility and included as illustrative material with a manuscript are exempt from this copyright transfer. The CJHP will require a letter from the hospital or health care facility granting permission to publish the document(s).